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readmission occurred with a statistically signiﬁcant difference at 24
months (p<0.05), but no signiﬁcant differences in other follow-up
time (p >0.05). Follow up of 24 months, 10 patients in the A group
recurrence of angina pectoris (23.26%), non fatal myocardial infarc-
tion in 0 cases. The B group had recurrence of angina pectoris in 24
cases (42.86%) of 5 cases of non fatal myocardial infarction (12.5%), a
statistically signiﬁcant.
CONCLUSIONS An important basis for
1. IVUS examination can be used as critical lesion for interventional
therapy.
2. IVUS check the critical disease intervention to obtain a relatively
high success rate and good clinical outcome.
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OBJECTIVES Emerging studies suggest that patients with complex
coronary lesions undergoing percutaneous coronary intervention
(PCI) have more major adverse cardiac events (MACE) than do those
with simple ones. Intensive antiplatelet therapy could reduce recur-
rent ischemic events in the patients with complex lesions. In the
present study, we evaluated the safety and efﬁcacy of routine dual
antiplatelet therapy plus low-dose cilostazol in patients with complex
coronary lesions undergoing PCI.
METHODS A total of 127 patients with complex lesions undergoing
PCI in Cardiology Department of the Second Hospital of Tianjin
Medical University from October 2012 to April 2014 were randomized
to receive: dual (aspirin plus clopidogrel, DAPT, n ¼66) or triple
antiplatelet therapy (aspirin plus clopidogrel plus cilostazol, TAPT,
n¼61). Patients in the TAPT group received adjunctive cilostazol
(100mg loading, followed by 50mg BID) for 3-6 months. The primary
endpoint was composite major adverse cardiac events (MACE). The
complex coronary target lesions were deﬁned as at least one of
followings: left main disease, severe 3-vessel disease, chronic total
occlusion (CTO) lesions, true bifurcation lesion (Medina classiﬁca-
tion: 1.1.1), ostial lesions of main vessels and highly thrombotic
lesions.
RESULTS The 2 groups had similar baseline clinical and angio-
graphic characteristics. One-year clinical outcomes showed that the
TAPT group had signiﬁcantly lower incidence of myocardial
infarction (1.6% vs 13.6%, P ¼0.018) and MACE (1.6% vs 16.7%,
P ¼0.004) than did the DAPT group. The DAPT group had 2 cases of
stent thrombosis, while the TAPT group didn’t have. Furthermore,
low-dose adjunctive cilostazol didn’t signiﬁcantly increase the
incidence of bleeding events (26.2% vs 19.7%, P ¼0.381) regardless
of major (4.9% vs 4.5%, P ¼0.921) or minor (21.3% vs 15.2%,
P ¼0.368) events.
CONCLUSIONS Low-dose adjunctive cilostazol seems to be superior
to dual antiplatelet therapy in reducing recurrent ischemic events
with similar rates of bleeding events in patients with complex coro-
nary lesions. Further study with larger population will be needed to
get the deﬁnite conclusions.
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OBJECTIVES To investigate the relationship of serum C1q/TNF-
related protein 5 (CTRP5) with coronary artery restenosis after
drug-eluting stent (DES) based percutaneous coronary intervention
(PCI).
METHODS Clinical characteristics, biochemical measurements, med-
ical treatments, left ventricular ejection fraction (LVEF), serum
CTRP5and coronary interventional features were assessed in
258 consecutive patients with angiographic ISR and 260 age- and
sex-matched patients without ISR at one-year after PCI withsirolimus-eluting stent implantation. Multivariate Logistic regression
analysis was performed to determine the independent factors for ISR.
RESULTS Compared with non-ISR patients, those with ISR had higher
incidence of prior myocardial infarction and were more likely to be
diabetic and cigarette smokers. Serum levels of low-density lipopro-
tein cholesterol (LDL-C), apoliprotein B, high-sensitivity C-reactive
protein, and glycosylated hemoglobin were higher, but LVEF was
lower in patients with ISR. Despite similar degree of coronary disease
and site of stent implantation, stent diameter was smaller, stent
length was longer, and bifurcation stenting was more common in
patients with ISR. The level of CTRP5 in ISR group was signiﬁcantly
higher than that in the control group (P < 0.05). Multivariate Logistic
regression analysis revealed that prior myocardial infarction
(OR¼3.23), diabetes (OR¼2.33), cigarette smoking (OR¼1.85), elevated
hs-CRP(OR¼1.06), LDL-C (OR¼1.30), and CTRP5 (OR¼1.51), and greater
stent length (OR¼1.08) were independent risk factors for ISR, whereas
stent diameter (OR¼0.39) and LVEF (OR¼0.94) were inversely asso-
ciated with ISR (all P<0.05).
CONCLUSIONS ISR after sirolimus-eluting stent implantation was
related to multiple clinical and coronary angiographic and interven-
tional factors. Elevated serum CTRP5 level is an independent pre-
dictor for ISR. Optimal control of traditional risk factors and
improvement of left ventricular function were crucial in reducing ISR,
particularly for patients with small vessel disease, long lesion (stents)
and bifurcation stenting. AR-SA’>, apoliprotein B, high-sensitivity C-
reactive protein, and glycosylated hemoglobin were higher, but LVEF
was lower in patients with ISR. Despite similar degree of coronary
disease and site of stent implantation, stent diameter was smaller,
stent length was longer, and bifurcation stenting was more common
in patients with ISR. The level of CTRP5 in ISR group was signiﬁcantly
higher than that in the control group (P < 0.05). Multivariate Logistic
regression analysis revealed that prior myocardial infarction
(OR¼3.23), diabetes (OR¼2.33), cigarette smoking (OR¼1.85), elevated
hs-CRP(OR¼1.06), LDL-C (OR¼1.30), and CTRP5 (OR¼1.51), and greater
stent length (OR¼1.08) were independent risk factors for ISR, whereas
stent diameter (OR¼0.39) and LVEF (OR¼0.94) were inversely asso-
ciated with ISR (all P<0.05).
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bifurcation lesions: Side branch balloon opening technique
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OBJECTIVES Coronary bifurcations (CB) are frequently encountered
and remain to be one of the most challenging lesion subsets for cor-
onary intervention. The main strategy nowadays to treat CB lesions
is the crossover technique. In brief, a stent was ﬁrstly implanted in
the main vessel and then branch kissing balloon or the stent-angio-
plasty performed in the side branch according to the side branch
stenosis.
METHODS Detailed steps are as follows:
(1) both SB and the main vessel are wired and then the small-
diameter balloon is advanced into the SB beforehand and makes sure
that the proximal portion of the balloon protrudes into the main
branch at a distance of 2 mm.
(2) After the main vessel predialation and stent implantation,
release the stent with minimum named pressure (8-10 atm).
(3) During the main vessel stent released with minimum named
pressure (10 atm), Sequent balloon in the ostium of side branch is
opening with6-8atm.
(4) After the 2.015 mm balloon was removed, the main vessel
stent balloon released with more pressure (14-16 atm), or A NC-
Sprinter balloon was put into the stent and post-dilated with 16 atm
pressure.
Here we present one case of coronary heart disease, which per-
formed this approach for side coronary bifurcations.
RESULTS The branch balloon opening technique has the following
advantages over the traditional side branch wire protection. It can
prevent the ostium of the side branch from aggravation. The stent
implantation in the main vessel makes the plaque shift or change the
kind of the stenosis, which will leads the compromise of the ostiumof
the side branch, occlusion or severe stenosis. Though there is report
that the jailed balloon can protect the ostium of the side branch, but
the just keep the balloon there or balloon the stent ﬁrst. Here we used
the technique that balloon open ﬁrst and then stent in nominal
pressure, the key point is that the opened balloon in the ostium can
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opening, the technique offers considerable promise for the prevention
of severe stenosis or occlusion in the ostium of the side branch and
reduces the possibility of the implementation of the main branch-side
branch kissing balloon or the stent-angioplasty in the side branch.
CONCLUSIONS As a result, the operation time and X-ray exposure
time are both shortened and the contrast agent dosage is decreased.
More importantly, it does not increase difﬁculty for the procedure.
This is why we choose the technique, which is effective, safe and
simple to handle.GW26-e3963
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OBJECTIVES An accumulating body of evidence indicates that slow
coronary ﬂow (SCF) phenomenon seems to be an early-form of
atherosclerosis and low-grade inﬂammation plays a major role in the
atherosclerotic vascular processes. Interleukin (IL)-10 is a multifunc-
tional anti-inﬂammatory cytokine involved in various physiological
and pathophysiological processes including cardiovascular disease.
The aim of the present study is to investigate the association of IL-10
gene promotor -592A/C polymorphism with SCF in Han Chinese.
METHODS 250 patients who underwent coronary angiography and
had angiographically normal coronary arteries of varying coronary
ﬂow rates without any atherosclerotic lesion were enrolled in this
study. Patients who had thrombolysis in myocardial infarction frame
counts (TFC) above the normal cutoffs were considered to have SCF
and those within normal limits were considered to have normal cor-
onary ﬂow (NCF). The PCR-based restriction fragment length poly-
morphism (PCR-RFLP) technique was used to assess the genotypes
frequencies.
RESULTS There were 41 patients in the SCF group and 209 patients in
the NCF group. The distribution of the IL-10 -592A/C genotypes (AA,
AC, and CC) was 46.34%, 41.46%, and 12.20% in the NCF group, and
66.51%, 28.71%, and 4.78% in SCF subjects, respectively (p ¼ 0.0280).
The frequency of the A allele in the SCF group was signiﬁcantly higher
than that in the NCF group (80.86% vs 67.07%, p ¼0.0054). Compared
with the CC genotype, the AA genotype had increased risk of SCF in
both unadjusted (OR¼3.6579, 95%CI¼1.1288-11.8533, p¼0.0386) and
adjusted analyses (OR¼2.9967, 95%CI¼1.0929-8.2173, p¼ 0.0357). In
SCF patients, the average serum IL-10 levels in AA genotype
(1.780.17 ng/L) were statistically lower than in ACþCC genotype
(2.100.20 ng/L) (p<0.001).
CONCLUSIONS These ﬁndings suggest that IL-10 -592A/C poly-
morphism is associated with SCF and the A allele has increased risk for
SCF in Han Chinese.GW26-e4553
Analysis of risk factors for revascularization after percutaneous coronary
invention of acute coronary syndrome
Zhongying Cao, Jun Liu
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OBJECTIVES percutaneous coronary invention (PCI) has been widely
used in the therapy of coronary heart disease (CHD) and obviously
improves the outcome of acute coronary syndrome (ACS) patients.
However, there are still many patients get clinical symptoms of CHD
after successful PCI, then they have to receive second revasculariza-
tion. The purpose of this retrospective study is to investigate the risk
factors of revascularization.
METHODS 510 patients undergoing CAG in the ﬁrst afﬁliated hospital
of Dalian medical university from 2010. 1 to 2014. 8 are accepted. 409
patients of them are received revascularization and we save the
clinical material of the ﬁrst and second PCI for the patients who
received several times of PCI. 101 patients are received coronary
angiography (CAG) that shows no coronary lesions and restenosis. We
estimate the baseline characteristics (age, sex, etal), cardiovascular
risk factor (hypertension, DM, etal), blood test indicators, ultrasonic
cardiogram of two groups. Then we divided patients received revas-
cularization into target lesion group (TLR), target vessel group (TVR),
non-target vessel group (NTVR), mixed lesion group (MLR) accordingto the way of revascularization. Continuous variables in subgroups are
analyzed by Student t test, variance analysis is used in multiple group
comparison, categorical variables are analyzed by Chi square test,
logistic analysis is used to analyze multivariate analysis. The P<0.05
is signiﬁcant in statistics.
RESULTS In revascularization group, mean age is 59.7510.34, male
328 (80.2%), and in control group, mean age is 60.2010.18, male 81
(80.2%). Referred to ﬁrst PCI, direct PCI patients (12.2% VS 2.9%, P ¼
0.029) and DM% (37.7% VS 27.7%, P ¼ 0.039) of revascularization
group are higher statistically, and age, sex, smoking, smoking index,
HP%, TC, TG, HDL, LDL, LPa, apolipoprotein A, apolipoprotein B,
cardiac function (EF, LVDD), CAG result are all statistically insigniﬁ-
cant between two groups. In the second PCI, LPa (271.74247.75 mg/l
VS 213.59192.09 mg/l, P ¼ 0.040), LDL-C (95.9729.84 mg/dl VS
87.3026.78 mg/dl, P ¼ 0.011) are higher and EF (54.987.79% VS
56.626.13%, P ¼ 0.040), the substandard LDL-C (100 mg/dl) %
(61.7% VS 71.7%, P ¼ 0.044) is lower in revascularization group. The
interval from ﬁrst PCI to second CAG, substandard TC (160 mg/dl)
are the independent risk factors for revascularization after PCI. In the
subgroups, patients of TVR are signiﬁcantly older than other groups,
substandard LDL% and LPa of NTVR and MLR are signiﬁcant higher
than controls.
CONCLUSIONS (1) This study indicates that DM, longer interval from
ﬁrst PCI to second CAG, substandard LDL and higher LPa may aggra-
vate the coronary lesions. (2) substandard TC after ﬁrst PCI and the
interval from ﬁrst PCI to second CAG are independent risk factors of
revascularization. (3) It’s necessary to control cardiovascular risk
factors after PCI, especially DM and lipidemia so to avoid re-
vascularization.GW26-e0702
Myocardial infarction of Double Versus Single Drug-Eluting Stent in
Patients With Coronary Bifurcations: A Meta-Analysis of Randomized
Controlled Trials
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OBJECTIVES The aim of this study was to conduct a meta-analysis
comparing the occurrence of myocardial infarction of double drug-
eluting stent (DDS) versus single drug-eluting stent (SDS) in patients
with coronary bifurcations.
METHODS 5 randomized, controlled trials, for a total of 1,813 patients,
comparing DDS versus SDS for the treatment of patients with coronary
bifurcations were included. The primary outcome was the occurrence
of myocardial infarction. The secondary outcome measures were
drug-eluting stent (DES) thrombosis, target vessel revascularization
(TVR) and overall mortality. The risk ratios (RRs) with 95% conﬁdence
intervals (CL) was the effect measure.
RESULTS The occurrence of MI was signiﬁcantly increased with DDS
compared with SDS (RR: 1.88; 95% CI: 1.35 to 2.62). There were no
signiﬁcant differences in DES thrombosis (RR: 2.01; 95% CI: 0.77 to
5.23), TVR (RR: 0.80; 95% CI: 0.55 to 1.17) and Overall mortality (RR:
0.66; 95% CI: 0.25 to 1.72) with DDS compared with SDS.
CONCLUSIONS For coronary bifurcations, treatment with DDS
showed a trend of more development of MI than did treatment with
SDS.
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OBJECTIVES To evaluate the safety and efﬁcacy of 135 cm Corsair
microcatheter for complex coronary lesion in Percutaneous Coronary
Intervention (PCI).
METHODS 65 patients with complex coronary lesions such as
chronic total occlusion (CTO), bifurcation lesions, severely calciﬁed
lesions, and seriously tortuosity of the coronary artery, which
treated with 135cm Corsair microcatheter (Asahi Intec Co, Japan),
was enrolled retrospectively in this study from January 2011 to
December 2014. The success rate of PCI was analyzed. Unique
complications related to the Corsair microcatheter during operation
